Short-term metabolic and haemodynamic effects of GR79236 in normal and fructose-fed rats

European Journal of Pharmacology

Volumn 338, Issue 3, 1997, Pages 269-276

  Qu, Xianqin ^a   Cooney, Gregory ^a,b   Donnelly, Richard ^a,c  

^a University of Sydney   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Fructose; GR79236; Insulin resistance; Lipolysis; Non insulin dependent diabetes (NIDDM); Triglyceride

Indexed keywords

6 N (2 HYDROXYCYCLOPENTYL)ADENOSINE; ADENOSINE RECEPTOR STIMULATING AGENT; FATTY ACID; FRUCTOSE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DYSLIPIDEMIA; GLUCOSE BLOOD LEVEL; HEART RATE; HYPERTENSION; INSULIN RESISTANCE; INTRAVENOUS GLUCOSE TOLERANCE TEST; LIPID METABOLISM; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RAT;

EID: 0030715266     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)81930-9     Document Type: Article

References (41)

1. Axelrod L., Lloyd-Jones P., Martin D.B. Correction of ketosis by suppression of lipolysis with 5-methylpyrazole-3-carboxylic acid in rats with established diabetic ketoacidosis. Diabetes. 28:1979;651-657.
2. 2 in experimental diabetic ketoacidosis in rats. Diabetes. 28:1979;905-913.
3. 6-cyclohexyl-2′-O-methyladenosine in patients with left ventricular dysfunction. Circulation. 94:1996;1212-1215.
4. Boden G., Chen X., Ruiz J., White J., Rossetti L. Mechanisms of fatty acid-induced inhibition of glucose uptake. J. Clin. Invest. 93:1994;2438-2446.
5. Buñag R.D. Validation in awake rats of a tail-cuff method for measuring systolic blood pressure. J. Appl. Physiol. 34:1973;279-282.
6. 1-mediated hemodynamic effects. J. Pharmacol. Exp. Ther. 268:1994;1506-1511.
7. Challis R.A.J., Richards S.J., Budohoski L. Characterization of the adenosine receptor modulating insulin action in skeletal muscle. Eur. J. Pharmacol. 226:1992;121-128.
8. Churchill P.C., Churchill M.C. A1 and A2 adenosine receptor activation inhibits and stimulates renin secretion of rat renal cortical slices. J. Pharmacol. Exp. Ther. 232:1985;589-594.
9. DeFronzo R., Bonadonna R., Ferrannini E. Pathogenesis of NIDDM. A balance overview. Diabetes Care. 15:1992;318-368.
10. Donnelly R., Plato P., Chang H., Reaven G.M. Effects of gemfibrozil on triglyceride metabolism in Dahl salt-sensitive rats. J. Pharmacol. Exp. Ther. 270:1994;809-813.
11. Donnelly R., Ho H., Reaven G.M. Effects of low sodium diet and unilateral nephrectomy on the development of fructose-induced hypertension. Blood Pressure. 4:1995;164-169.
12. Ebeling P., Koivisto V.A. Non-esterified fatty acids regulate lipid and glucose oxidation and glycogen synthase activity. Diabetologia. 37:1994;202-209.
13. Fredholm B.B., Abbrachio M.P., Burnstock G., Daly J.W., Harden K., Jacobson K.A., Leff P., Williams M. Nomenclature and classification of purinoceptors. Pharmacol. Rev. 46:1994;143-156.
14. Gardner C.J., Twissell D.J., Coates J., Strong P. The effects of GR79236 on plasma fatty acid concentrations, heart rate and blood pressure in the conscious rat. Eur. J. Pharmacol. 257:1994;117-121.
15. Green A. Adenosine receptor down regulation and insulin resistance following prolonged incubation of adipocytes with an A1 adenosine receptor agonist. J. Biol. Chem. 262:1987;15702-15707.
16. Green A., Johnson J.L. Evidence for impaired coupling of receptors to Gi protein in adipocytes from streptozotocin-induced diabetic rats. Diabetes. 40:1991;88-94.
17. Heseltine L., Webster J.M., Taylor R. Adenosine effects upon insulin action on lipolysis and glucose transport in human adipocytes. Mol. Cell. Biochem. 144:1995;147-151.
18. Hwang I., Ho H., Hoffman B.B., Reaven G.M. Fructose-induced insulin resistance and hypertension in the rat. Hypertension. 10:1987;512-516.
19. Kuroda M., Honnor R.C., Cushman S.W., Londos C., Simpson I.A. Regulation of insulin-stimulated glucose transport in the isolated rat adipocyte. cAMP-independent effects of lipolytic and antilipolytic agents. J. Biol. Chem. 262:1987;245-253.
20. LaNoue K.F., Martin L.F. Abnormal A1 adenosine receptor function in genetic obesity. FASEB J. 8:1994;72-80.
21. Lee H.T., Thompson C.I., Hernandez A., Lewy J.L.S., Belloni F.L. Atrial desensitization to adenosine receptor agonists following prolonged infusion of R-PIA in rats. FASEB J. 7:1993;A463. Abstr.
22. Lee K.-U., Park J.Y., Kim C.H., Hong S.K., Suh K.I., Park K.S., Park S.W. Effect of decreasing plasma free fatty acids by acipimox on hepatic glucose metabolism in normal rats. Metabolism. 45:1996;1408-1414.
23. Lillioja S., Bogardus C., Mott D., Kennedy L.A., Knowler W.C., Howard B.V. Relationship between insulin-mediated glucose disposal and lipid metabolism in man. J. Clin. Invest. 75:1985;1106-1115.
24. Londos C., Honnor R.C., Dhillon G.S. cAMP dependent protein kinase and lipolysis in rat adipocytes: (3) Multiple modes of insulin regulation of lipolysis and regulation of insulin responses by adenylyl cyclase regulators. J. Biol. Chem. 260:1985;15139-15145.
25. Massi M., Saija A., Cristalli G., Polidori C., Perfumi M., Costa G. Release of atrial natriuretic factor induced by the A1 adenosine receptor agonist 2-chloro-N6-cyclopentyladenosine in the rat. Pharmacol. Res. 25:1992;393-402.
26. Merkel L.A., Hawkins E.D., Colussi D.J., Greenland B.D., Smits G.J., Perrone M.H., Cox B.F. Cardiovascular and antilipolytic effects of the adenosine agonist GR 79236. Pharmacology. 51:1995;224-236.
27. Mondon C., Reaven G.M. Evidence of abnormalities of insulin metabolism in rats with spontaneous hypertension. Metabolism. 37:1988;303-305.
28. Myles D.D., Stratton G.D., Strong P., Skidmore I.F. The development of tolerance to antilipolytic agents in rats. Biochem. Pharmacol. 34:1985;269-274.
29. Olsson R.A., Pearson J.D. Cardiovascular purinoceptors. Physiol. Rev. 70:1990;761-845.
30. Otway S., Robinson D. The effect of a nonionic detergent (Triton WR 1339) on the removal of triglyceride fatty acid from the blood of the rat. J. Physiol. (London). 190:1967;309-319.
31. Otway S., Robinson D. The use of nonionic detergent (Triton WR 1339) to determine rates of triglyceride entry into the circulation of the rat under different physiological conditions. J. Physiol. (London). 190:1967;321-332.
32. Paolisso G., Tataranni P.A., Foley J.E., Bogardus C., Howard B.V., Ravussin E. A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM. Diabetologia. 38:1995;1213-1217.
33. Randle P.J., Hales C.N., Garland P.B., Newsholme E.A. The glucose-fatty acid cycle. Its role in insulin insensitivity and the metabolic disturbances of diabetes mellitus. Lancet. i:1963;785-789.
34. Reaven G.M., Chang H., Ho H., Jeng C.-Y., Hoffman B.B. Lowering of plasma glucose in diabetic rats by antilipolytic agents. Am. J. Physiol. 254:1988;E23-E30.
35. Reaven G.M., Ho H., Hoffman B.B. Attenuation of fructose-induced hypertension and insulin resistance in rats by exercise training. Hypertension. 12:1988;129-132.
36. Saloranta C., Koivisto V., Widen E., Falholt K., Defronzo R., Harkonen M., Groop L. Contribution of muscle and liver to glucose-fatty acid cycle in humans. Am. J. Physiol. 264:1993;E599-605.
37. Simon J.A., Fong J., Bernett J.T. Serum fatty acids and blood pressure. Hypertension. 27:1996;303-307.
38. Stansbie D., Brownsey R., Crettaz M., Denton R. Acute effects in vivo of anti-insulin serum on rates of fatty acid synthesis and activities of acetyl-coenzyme a carboxylase and pyruvate dehydrogenase in liver and epididymal adipose tissue of fed rats. Biochem. J. 160:1976;413-416.
39. Strong P., Anderson R., Coates J., Ellis F., Evans B., Gurden M.F., Johnstone J., Kennedy I., Martin D.P. Suppression of non-esterified fatty acids and triglycerides in experimental animals by the adenosine analogue GR79236. Clin. Sci. 84:1993;663-669.
40. Thompson C.S., Strong P., Mikhailidis D.P. Improvement of ketoacidosis in the diabetic rat after the administration of the oral antilipolytic agent GR79236. Clin. Sci. 86:1994;593-598.
41. Tobey T., Mondon C., Zavaroni I., Reaven G.M. Mechanism of insulin resistance in fructose-fed rats. Metabolism. 31:1982;608-612.